This inventor holds 1 USPTO granted patent. Top assignee: Pasteur Merieux. Active years: 1994.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1994
Title: The Innovations of Charles Lutsch
Introduction
Charles Lutsch is a notable inventor based in Grezieu La Varenne, France. He has made significant contributions to the field of biochemistry, particularly in the purification of factor VIII, a crucial component in blood coagulation.
Latest Patents
Lutsch holds a patent for a method for purifying factor VIII and the preparations obtained from it. The method involves dissolving cryoprecipitate and treating it with alumina gel. The extract is then diluted to a protein concentration not exceeding approximately 5 g/l and subjected to viral inactivation using solvent/detergent. Following this, the inactivated extract containing the solvent/detergent undergoes chromatography on a weak anion exchange column that is hydrophilic in nature. Finally, factor VIII is eluted with a dissociating buffer. This innovative approach enhances the safety and efficacy of factor VIII preparations.
Career Highlights
Charles Lutsch is associated with Pasteur Merieux, a company known for its advancements in the field of vaccines and biopharmaceuticals. His work at this institution has allowed him to focus on critical research that impacts healthcare.
Collaborations
Lutsch has collaborated with Michel G Grandgeorge, contributing to the advancement of their shared research interests in biochemistry and pharmaceutical sciences.
Conclusion
Charles Lutsch's innovative methods in purifying factor VIII demonstrate his commitment to improving medical treatments. His contributions are vital in the ongoing efforts to enhance patient care and safety in the field of biochemistry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile